Table 5.
Comparison of analgesic drug use between the two groups, n (%)
|
|
None
|
Nonopioid analgesic
|
Moderate opioid
|
Strong opioid
|
P value
|
|
| After 1 month | Double-stent group | 24 (60.0) | 13 (32.5) | 1 (2.5) | 2 (5.0) | 0.026 |
| Single-stent group | 11 (28.9) | 19 (42.1) | 5 (13.2) | 3 (7.9) | ||
| After 2 months | Double-stent group | 22 (55.0) | 14 (35.0) | 2 (5.0) | 2 (5.0) | 0.051 |
| Single-stent group | 10 (26.3) | 18 (47.4) | 4 (10.5) | 6 (15.8) | ||
| After 3 months | Double-stent group | 19 (57.5) | 18 (57.5) | 1 (2.5) | 2 (5.0) | < 0.001 |
| Single-stent group | 6 (15.8) | 14 (36.8) | 8 (21.1 | 10 (36.3) | ||
| After 6 months | Double-stent group | 16 (40.0) | 16 (40.0) | 5 (12.5) | 3 (7.5) | < 0.001 |
| Single-stent group | 3 (7.9) | 3 (7.9) | 16 (42.1) | 16 (42.1) | ||
The double-stent group underwent endoscopic retrograde cholangiopancreatography with a fully-covered self-expandable metallic biliary stent and a pancreatic duct stent, while the single-stent group underwent a fully-covered self-expandable metallic biliary stent only.